Screener
Intellia Therapeutics NTLA Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating loss | (112,760) | (109,996) | (213,292) | (230,803) |
| Other income, net: | ||||
| Interest income | 5,797 | 7,402 | 11,002 | 16,005 |
| Change in fair value of investments, net | 329 | 1,339 | (575) | (786) |
| Total other income, net | 6,126 | 8,741 | 10,427 | 15,219 |
| Net loss | $(106,634) | $(101,255) | $(202,865) | $(215,584) |
| Net loss per share, basic and diluted | $(0.80) | $(0.98) | $(1.61) | $(2.08) |
| Weighted average shares outstanding, basic and diluted | 133,480 | 103,732 | 126,057 | 103,617 |
Item 1. Financial Statements
FAQ
- What is Intellia Therapeutics's net gains (losses) on investments?
- Intellia Therapeutics (NTLA) reported net gains (losses) on investments of $329K in Q2 2026.
- How has Intellia Therapeutics's net gains (losses) on investments changed year-over-year?
- Intellia Therapeutics's net gains (losses) on investments decreased by 75.4% year-over-year, from $1.34M to $329K.
- What is the long-term trend for Intellia Therapeutics's net gains (losses) on investments?
- Over 4 years (2021 to 2025), Intellia Therapeutics's net gains (losses) on investments has grown at a -100.0% compound annual growth rate (CAGR), from -$1.33M to $0.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.
Ask your AI about Intellia Therapeutics's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude